FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2096783631> ?p ?o ?g. }

• W2096783631 endingPage "e60" @default.
• W2096783631 startingPage "e53" @default.
• W2096783631 abstract "Approximately one fourth of bone and soft-tissue sarcomas recur after prior treatment. GLV-1h68 is a recombinant, replication-competent vaccinia virus that has been shown to have oncolytic effects against many human cancer types. We sought to determine whether GLV-1h68 could selectively target and lyse a panel of human bone and soft-tissue sarcoma cell lines in vitro and in vivo.GLV-1h68 was tested in a panel of four cell lines including: fibrosarcoma HT-1080, osteosarcoma U-2OS, fibrohistiocytoma M-805, and rhabdomyosarcoma HTB-82. Gene expression, infectivity, viral proliferation, and cytotoxicity were characterized in vitro. HT-1080 xenograft flank tumors grown in vivo were injected intratumorally with a single dose of GLV-1h68.All four cell lines supported robust viral transgene expression in vitro. At a multiplicity of infection (MOI) of five, GLV-1h68 was cytotoxic to three cell lines, resulting in >80% cytotoxicity over 7 d. In vivo, a single injection of GLV-1h68 into HT-1080 xenografts exhibited localized intratumoral luciferase activity peaking at d 2-4, with gradual resolution over 8 d and no evidence of spread to normal tissues. Treated animals exhibited near-complete tumor regression over a 28-d period without observed toxicity.GLV-1h68 has potent direct oncolytic effects against human sarcoma in vitro and in vivo. Recombinant vaccinia oncolytic virotherapy could provide a new platform for the treatment of patients with bone and soft tissue sarcomas. Future clinical trials investigating oncolytic vaccinia as a therapy for sarcomas are warranted." @default.
• W2096783631 created "2016-06-24" @default.
• W2096783631 creator A5005824918 @default.
• W2096783631 creator A5013313803 @default.
• W2096783631 creator A5023099437 @default.
• W2096783631 creator A5041054317 @default.
• W2096783631 creator A5051659038 @default.
• W2096783631 creator A5057322881 @default.
• W2096783631 creator A5064366243 @default.
• W2096783631 creator A5070616777 @default.
• W2096783631 creator A5071370261 @default.
• W2096783631 creator A5072015440 @default.
• W2096783631 creator A5078178893 @default.
• W2096783631 date "2012-06-01" @default.
• W2096783631 modified "2023-10-05" @default.
• W2096783631 title "Effective Oncolytic Vaccinia Therapy for Human Sarcomas" @default.
• W2096783631 cites W1534142361 @default.
• W2096783631 cites W1965497380 @default.
• W2096783631 cites W1965855782 @default.
• W2096783631 cites W1996714594 @default.
• W2096783631 cites W2005431829 @default.
• W2096783631 cites W2016141222 @default.
• W2096783631 cites W2020849247 @default.
• W2096783631 cites W2026108602 @default.
• W2096783631 cites W2038815047 @default.
• W2096783631 cites W2042280035 @default.
• W2096783631 cites W2049929561 @default.
• W2096783631 cites W2058025467 @default.
• W2096783631 cites W2076429505 @default.
• W2096783631 cites W2079647238 @default.
• W2096783631 cites W2090992543 @default.
• W2096783631 cites W2100342970 @default.
• W2096783631 cites W2101058247 @default.
• W2096783631 cites W2108595427 @default.
• W2096783631 cites W2122962340 @default.
• W2096783631 cites W2124226236 @default.
• W2096783631 cites W2136246490 @default.
• W2096783631 cites W2137141962 @default.
• W2096783631 cites W2155544754 @default.
• W2096783631 cites W2158734599 @default.
• W2096783631 cites W2160277474 @default.
• W2096783631 doi "https://doi.org/10.1016/j.jss.2011.11.1030" @default.
• W2096783631 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3350611" @default.
• W2096783631 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22341347" @default.
• W2096783631 hasPublicationYear "2012" @default.
• W2096783631 type Work @default.
• W2096783631 sameAs 2096783631 @default.
• W2096783631 citedByCount "25" @default.
• W2096783631 countsByYear W20967836312013 @default.
• W2096783631 countsByYear W20967836312014 @default.
• W2096783631 countsByYear W20967836312015 @default.
• W2096783631 countsByYear W20967836312016 @default.
• W2096783631 countsByYear W20967836312017 @default.
• W2096783631 countsByYear W20967836312018 @default.
• W2096783631 countsByYear W20967836312020 @default.
• W2096783631 crossrefType "journal-article" @default.
• W2096783631 hasAuthorship W2096783631A5005824918 @default.
• W2096783631 hasAuthorship W2096783631A5013313803 @default.
• W2096783631 hasAuthorship W2096783631A5023099437 @default.
• W2096783631 hasAuthorship W2096783631A5041054317 @default.
• W2096783631 hasAuthorship W2096783631A5051659038 @default.
• W2096783631 hasAuthorship W2096783631A5057322881 @default.
• W2096783631 hasAuthorship W2096783631A5064366243 @default.
• W2096783631 hasAuthorship W2096783631A5070616777 @default.
• W2096783631 hasAuthorship W2096783631A5071370261 @default.
• W2096783631 hasAuthorship W2096783631A5072015440 @default.
• W2096783631 hasAuthorship W2096783631A5078178893 @default.
• W2096783631 hasBestOaLocation W20967836312 @default.
• W2096783631 hasConcept C104317684 @default.
• W2096783631 hasConcept C142724271 @default.
• W2096783631 hasConcept C150903083 @default.
• W2096783631 hasConcept C159047783 @default.
• W2096783631 hasConcept C202751555 @default.
• W2096783631 hasConcept C203233990 @default.
• W2096783631 hasConcept C207001950 @default.
• W2096783631 hasConcept C2522874641 @default.
• W2096783631 hasConcept C2776495794 @default.
• W2096783631 hasConcept C2778256501 @default.
• W2096783631 hasConcept C2779094796 @default.
• W2096783631 hasConcept C2780844630 @default.
• W2096783631 hasConcept C2781356689 @default.
• W2096783631 hasConcept C40767141 @default.
• W2096783631 hasConcept C502942594 @default.
• W2096783631 hasConcept C54355233 @default.
• W2096783631 hasConcept C55493867 @default.
• W2096783631 hasConcept C71924100 @default.
• W2096783631 hasConcept C81885089 @default.
• W2096783631 hasConcept C82210918 @default.
• W2096783631 hasConcept C86803240 @default.
• W2096783631 hasConceptScore W2096783631C104317684 @default.
• W2096783631 hasConceptScore W2096783631C142724271 @default.
• W2096783631 hasConceptScore W2096783631C150903083 @default.
• W2096783631 hasConceptScore W2096783631C159047783 @default.
• W2096783631 hasConceptScore W2096783631C202751555 @default.
• W2096783631 hasConceptScore W2096783631C203233990 @default.
• W2096783631 hasConceptScore W2096783631C207001950 @default.
• W2096783631 hasConceptScore W2096783631C2522874641 @default.
• W2096783631 hasConceptScore W2096783631C2776495794 @default.

• next